Anthony DiGiandomenico
On the Effective Date, the Board increased the size of the Board from five to seven directors and appointed each New Director as a member of the Board, effective immediately
Highest-materiality recent filing
ClearSign Q4 revenue $3.7M record; FY revenue $5.2M +44% YoY
Q4 2025 revenue $3.7M (record); FY revenue $5.2M, up 44% YoY.
Reverse stock split approved at ratio between 1-for-2 and 1-for-10, with board discretion to abandon.
ClearSign preliminary Q4 revenue ~$3.6M (+510% YoY), FY revenue ~$5.2M (+44% YoY)
Preliminary Q4 2025 revenue of approx $3.6M, up 510% from $590K in Q4 2024.
ClearSign receives Nasdaq extension to March 2026 to regain $1 bid price compliance
Received 180-day extension from Nasdaq; compliance deadline now March 30, 2026.
ClearSign receives Nasdaq non-compliance notice over board independence; two directors resign
On August 8, 2025, Nasdaq notified ClearSign it fails board independence and audit committee composition requirements due to resignations of directors de Lacy and Schrecker.
ClearSign enters $10.39M ATM equity facility with H.C. Wainwright; terminates prior $8.7M ATM
Entered ATM Agreement with H.C. Wainwright & Co. for up to $10,390,000 of common stock, dated July 17, 2025.
Board expanded from 5 to 7; appointed Louis Basenese and Anthony DiGiandomenico effective May 22, 2025.
On the Effective Date, the Board increased the size of the Board from five to seven directors and appointed each New Director as a member of the Board, effective immediately
On the Effective Date, the Board increased the size of the Board from five to seven directors and appointed each New Director as a member of the Board, effective immediately
Max materiality 0.80 · Median 0.50 · Most common event other_material